2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Updated BEACON Results on BRAF V600E mCRC: Is the FDA Approval of Encorafenib + Cetuximab Practice Changing?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Richard Kim
By 2020 ASCO Virtual Direct™ Highlights FEATURING Richard Kim
320 views
August 20, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
GI
07:16
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updated BEACON Results on BRAF V600E mCRC: Is the FDA Appr…

Feat. R. Kim
05:38
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Pembro vs. Chemo in 1L dMMR / MSI-H mCRC: Did Re…

Feat. R. Kim
07:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mCRC: Can 3L T-DXd Be Effective in HER2+ Disease?

Feat. R. Kim
05:15
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Stage III Rectal Cancer: Neoadjuvant Short-Cours…

Feat. R. Kim
06:14
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Rectal Adenocarcinoma: Can Patients With a cCR t…

Feat. R. Kim